At 35, founder Conno Christou was already living by the rules of precision: wearable data, annual bloodwork, and a routine shaped by longevity research. Then a post-workout arm swelling led to a medical checkup that revealed blood clots and, unexpectedly, a large mass behind his sternum.
Tests confirmed an aggressive, fast-growing form of non-Hodgkin's lymphoma, a rare diagnosis that had developed over just a few months. What followed was not only treatment, but a deep dive into how modern patients can combine expert care, personal data, and AI tools to make better-informed decisions.
After receiving two different chemotherapy recommendations, Christou sought a wider range of opinions and ultimately collected 12 expert views. The majority supported the more intensive regimen, and he chose that path. Throughout treatment, he tracked sleep, symptoms, nutrition, and lab results, using a Whoop band and a detailed voice journal to monitor patterns in his recovery.
He also entered scans, bloodwork, and notes into Claude, using the AI system not as a replacement for doctors, but as a way to ask sharper questions. In one key moment, the model helped identify a likely thymus rebound on a final PET scan, a known effect in younger patients after this type of therapy. A later medical review confirmed there was no active disease.
Christou's experience also shaped his view of healthcare operations. As the founder of Keragon, an AI platform for medical administration, he says the patient journey showed him how much time clinicians spend on tasks that could be streamlined. His story reflects a growing shift: AI is becoming a practical layer of support in health decision-making, especially when paired with human expertise.
His recovery now includes a slower rhythm, more presence, and a clearer sense of what matters beyond productivity. The bigger picture is simple: as AI tools mature, they may help patients and doctors move toward faster, more personalized care in the years ahead.